depression

Top solutions to lower drug pricesPBMs partnering with pharmacies and drug makers may have a solution to nonadherence due to high pharma costs.
Depression: How to treat, avoid misdiagnosisDepression is one of the most common diagnosed disorders but providers still have trouble diagnosing and treating these patients.
When Switching Meds Isn’t the Best Approach
When Switching Meds Isn’t the Best ApproachStudy finds that adding an antipsychotic to antidepressant therapy may be best for treating depression.
One plan’s unique approach to combat diabetes, obesityThis novel approach aims to help those already struggling with obesity and diabetes, but eventually win the fight against this epidemic.
Behavioral health top priority for employersWith a growing need for services, nearly nine in 10 employers cite behavioral health as an important priority in Willis Towers Watson survey.
Small Doses: Pharmacy News Featuring Opioids, Ketamine, and More
Small Doses: Pharmacy News Featuring Opioids, Ketamine, and MoreSmall Doses is news for pharmacists in a way that works for you.
Small Doses: News for Pharmacists
Small Doses: News for PharmacistsThis week, take a look at studies and news on supplements, depression, opioids, and more. Small doses is the news you need in a way that works for you.
How to target high-risk populations with behavioral healthHere are four of the top benefits of incorporating behavioral health management into care management plans for members with chronic conditions.
Your New Role in the Battle Against Depression
Your New Role in the Battle Against DepressionA shortage of mental health-care providers, coupled with pharmacists’ unique skills and access to patients, has led to a significant opportunity for community and health-system pharmacists to aid in detection of depression and in medication selection and counseling for patients with depression.
Generic versions of major depression drug availableMylan received approval from FDA to market its desvenlafaxine extended-release tablets, the generic version of Pristiq (Pfizer), for major depressive disorder. Plus, 2 other manufacturers recently received approval for their generic versions of Pristiq.